CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC

Develops and manufactures diagnostic tests for food sensitivity and gut health.

CNSL | IL

Overview

Corporate Details

ISIN(s):
GB00B1CS9459 (+1 more)
LEI:
2138007U9P4BTZTYIR92
Country:
United Kingdom
Address:
EDEN RESEARCH PARK, CB6 1SE LITTLEPORT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cambridge Nutritional Sciences PLC is a specialist medical diagnostics company that develops, manufactures, and distributes diagnostic products for the food sensitivity testing market. The company promotes a personalized and functional approach to health, specializing in a range of tests associated with food sensitivity and gut health. Utilizing advanced diagnostic technology, it enables healthcare professionals and their patients to identify potential dietary and lifestyle changes to improve long-term wellbeing. As a pioneer in its field, the company leverages its expertise to provide tools for managing health through nutrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 17:30
Post-Annual General Meeting Information
Result of AGM
English 9.2 KB
2025-08-28 08:00
Report Publication Announcement
Notice of AGM & Annual Report
English 9.3 KB
2025-08-21 08:00
Remuneration Information
Grant of Options
English 17.1 KB
2025-08-19 08:00
Annual Report
Final Results
English 941.0 KB
2025-07-31 08:00
Report Publication Announcement
Notice of Results & Investor Presentation
English 13.8 KB
2025-07-10 08:00
Board/Management Information
Directorate Change
English 18.8 KB
2025-07-02 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.2 KB
2025-05-27 08:00
Earnings Release
Trading Update
English 14.1 KB
2025-05-23 08:00
Legal Proceedings Report
Resolution on HSE Matter
English 13.5 KB
2025-03-19 08:00
Legal Proceedings Report
Omega Diagnostics Summons Update
English 12.1 KB
2025-03-18 15:48
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-02-06 08:00
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-30 10:41
Director's Dealing
Director/PDMR Shareholding
English 30.7 KB
2025-01-21 17:03
Legal Proceedings Report
Omega Diagnostics court summons
English 12.4 KB
2025-01-16 08:00
Legal Proceedings Report
Settlement of DHSC Claim
English 13.5 KB

Automate Your Workflow. Get a real-time feed of all CAMBRIDGE NUTRITIONAL SCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAMBRIDGE NUTRITIONAL SCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Elicera Therapeutics AB Logo
Develops CAR T-cell & oncolytic virus therapies for cancer, enhanced by its iTANK platform.
Sweden ELIC
Ellen AB Logo
Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.
Sweden ELN
Enlivex Therapeutics Ltd. Logo
Developing cell therapy to restore immune balance for inflammatory diseases like sepsis.
Israel ENLV
Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden ERMA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea 183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea 446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden EQL
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France ERYP
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea 206650

Talk to a Data Expert

Have a question? We'll get back to you promptly.